All Industries

Top Biotech Companies

3,960 Biotech companies, sorted by total funding raised.

Scorpion Therapeutics

Targeted oncology therapies

Boston, United States51–200Biotech, Healthcare
Series C·$420.0M·Jul 2024
Enzene Biosciences

Global biologics CDMO specializing in biosimilars development, manufacturing, and continuous biop...

IndiaBiotech, Contract Manufacturing
Private Equity·$412.0M·Dec 2025
Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therap...

London, United Kingdom11–50Life Sciences, Biotech
Series A·$411.0M·Jan 2025
CT
CRISPR TherapeuticsIPO

Life sciences company

Zug, Switzerland201–500Biotech, Life Sciences
Venture Round·$410.5M·Feb 2024
CStone PharmaceuticalsIPO

Innovation-driven biopharmaceutical company focused on immuno-oncology and molecularly targeted t...

Suzhou, China201–500Biotech, Healthcare
Series B·$410.0M·May 2018
Sonoma Biotherapeutics

Develops engineered regulatory T cell therapies to restore immune balance and treat autoimmune an...

Seattle, United States51–200Biotech, Life Sciences
Corporate Round·$410.0M·Sep 2024
Abcuro

Abcuro is a clinical-stage company developing Ulviprubart, a FIC anti-KLRG1 antibody in Ph2/3 piv...

Newton, United States51–200Biotech, Healthcare
Series C·$407.3M·Feb 2025
BillionToOneIPO

The genetic testing platform detecting and measuring disease.

Menlo Park, United States201–500Biotech, Diagnostics
Venture Round·$406.0M·Mar 2026
Athelas

Digital tools for healthcare providers

Mountain View, United States51–200Biotech, Healthcare
Growth Equity·$404.0M·Jun 2025
D
Dianthus

Clinical-stage biotech developing next-generation complement antibody therapeutics for rare autoi...

United StatesBiotech, Healthcare
Venture Round·$400.0M·Sep 2023
Upstream BioIPO

Clinical-stage biotechnology company developing treatments for inflammatory diseases, with an ini...

Waltham, United States51–200Biotech, Healthcare
Series B·$400.0M·Jun 2023
VerastemIPO

Biopharmaceutical company developing RAS/MAPK pathway therapies for cancer patients.

Boston, United States51–200Biopharmaceutical, Healthcare
Corporate Round·$392.5M·Nov 2025
SuperGenClosed

Pharmaceutical company dedicated to the discovery and development of novel cancer therapies.

Dublin, United States201–500Biotech
Corporate Round·$391.6M·Oct 2009
Believer Meats

Mission to make it possible for all future generations to eat meat

Chicago, United States51–200Biotech, cultured meat
Series B·$390.3M·Dec 2021
Artios Pharma

DNA damage response biology for precision cancer medicines

Cambridge51–200Biotech, Healthcare
Series D·$384.5M·Nov 2025
23andMeIPO

Developing new ways to help people make sense of their genetic information

San Francisco Bay Area, United States501–1000Biotech, DNA Testing
Series B·$382.5M·Dec 2020
Jade BiosciencesAcquired

Jade Biosciences develops innovative biologics and disease-modifying therapies targeting autoimmu...

Waltham, United States11–50Biotech, Healthcare
Corporate Round·$380.0M·Apr 2025
SaludaIPO

Neurostimulation company developing closed-loop spinal cord stimulation technology for chronic pa...

Macquarie Park, AustraliaBiotech, Healthcare
Growth Equity·$375.0M·Jan 2025
MapLight TherapeuticsIPO

AI-powered neuroscience drug discovery platform for CNS diseases.

San Francisco, United States51–200Artificial Intelligence, Biotech
Series D·$372.5M·Jul 2025
Formation Bio

Tech-native pharma company acquiring and developing clinical-stage assets via proprietary sourcin...

New York, United States51–200Artificial Intelligence, Biotech
Series D·$372.0M·Jun 2024
Definium Therapeutics, Inc. Common SharesIPO

Clinical-stage biopharmaceutical company (formerly MindMed) developing psychedelic-based psychiat...

New York City, United States11–50Biotech, Healthcare
Corporate Round·$371.0M·Aug 2023
Tizona Therapeutics

Clinical-stage oncology company developing first-in-class cancer immunotherapy treatments targeti...

South San Francisco, United States11–50Biotech, Healthcare
Corporate Round·$370.0M·Jul 2020
Human Longevity

Biotech startup focused on innovative longevity and precision medicine technologies

San Diego, United States51–200Biotech
Series B·$369.8M·Aug 2024
Vividion TherapeuticsAcquired

Vividion Therapeutics is a Bayer-owned biopharmaceutical company using chemoproteomics-based drug...

San Diego, United States201–500Biotech, Drug Discovery
Series C·$368.0M·Feb 2021
TE
Thrive Earlier DetectionClosed

Liquid biopsy cancer screening company integrating multi-cancer early detection into routine medi...

Cambridge, United States51–200Biotech, Diagnostics
Series B·$367.0M·Jul 2020